Ventus is a technological company, specialising in innovative nicotine inhalation products.
We are developing the next generation of medical devices. Combining function of ENDS with safety of pharmaceuticals, we are leading the way in manufacturing, regulation and user experience.
We are developing the next generation of medical devices. Combining function of ENDS with safety of pharmaceuticals, we are leading the way in manufacturing, regulation and user experience.
Location: United Kingdom, England, Liverpool
Employees: 11-50
Total raised: $40M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Advent Lif... | adventls.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.07.2010 | Series D | $40M | - |
Mentions in press and media 3
| Date | Title | Description |
| 08.04.2021 | Ventus raises $100M to pursue NLRP3, crack undruggable targets | Ventus Therapeutics has raised a $100 million series B to take small molecules against traditionally undruggable targets into clinical trials. The pipeline features NLRP3 inhibitors that Ventus is pitching as best-in-class candidates in the... |
| 13.07.2010 | Ventus Medical Closes $40M Series D Financing | Ventus Medical, Inc., a Belmont, CA-based medical device company focused on transforming the treatment of sleep disordered breathing, has closed a $40m Series D financing. The new capital will enable the company to expand commercialization ... |
| 13.07.2009 | Ventus Funds reach £50m for venture capital investment in UK renewable energy projects | The Ventus Funds have now raised over £50m since their launch in 2005. The Ventus Funds are specialist venture capital |